SECTION I: ESTIMATION OF COSTS
1 | Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
… in terms of IPR protection
The product is IPR protected (no cost) |
|
…in terms of product development
2 developers ( 1600 – 2000 € salary) hardware : servers, pcs, screens ( 5000 €) |
|
…in terms of mass production
There are no mass production costs |
|
… in terms of marketing
The marketing costs involve promotion actions to users . The marketing costs are estimated around 15000 € per year, for leaflets, TV reports, advertising in magazines and web sites, participation in exhibitions, testimonies, events etc. |
2 | Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs (€) | |||||
Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | ||
Fixed costs | ||||||
Personnel | 40000 | 50000 | 60000 | 60000 | 60000 | |
Other running costs | 5000 | |||||
Marketing costs | 15000 | 15000 | 15000 | 15000 | 15000 | |
TOTAL EXPECTED COSTS | 60000 | 65000 | 75000 | 75000 | 75000 | |
Price per Unit | 1000 | 1000 | 1000 | 1000 | 1000 | |
Type of Unit | annual use of the software | |||||
Number of Units | 100 | 200 | 300 | 300 | 300 | |
TOTAL Expected Revenues | 100000 | 200000 | 300000 | 300000 | 300000 | |
CASH FLOW REQUIRED (REVENUES-COSTS) | ||||||
TOTAL CAPITAL required for five years | ||||||
SECTION 2: QUALITATIVE FACTORS
3 | Dimension of identified target groups |
The goal of this product should be the distribution in all the English speaking markets and Greece. By using an intense advertising campaign in the US, UK, Canada, Australia and Greece, the product can easily start making profits. The goal is to sell in these markets 100 units in the first and 200 in the second year. |
4 | Evaluation of financial Risks for R&D result |
The financial risks for this result are small, since there is already active demand for the product. The lack of similar products in the market is also very important. However, the geographical diversity of the users is an obvious obstacle to the product’s promotion. Therefore, assuming that sales during the first year is an unachievable goal, the marketing costs constitute the financial risks for the product. |
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc
1. European Funding |
- EUREKA’s Eurostars Programme is the first European funding and support programme to be specifically dedicated to small and medium-sized enterprises.
- Competitiveness and Innovation framework Programme (CIP) supports innovation activities, provides better access to finance and delivers business support services in the regions. With small and medium-sized enterprises (SMEs) as its main target, it encourages a better take-up and use of information and communication technologies (ICT) and helps to develop the information society. - JEREMIE, Joint European Resources for Micro to medium Enterprises, is an initiative of the Commission together with the European Investment Bank and the European Investment Fund in order to promote increased access to finance for the development of micro, small and medium-sized enterprises in the regions of the EU. - INTERREG IVC Programme provides funding for interregional cooperation across Europe and lasts from 2007-2013. The overall objective of the INTERREG IVC Programme is to improve the effectiveness of regional policies and instruments. The areas of support are innovation, environment and risk prevention. |
2. National Funding |
- National Strategic Reference Framework (ΕΣΠΑ) could be used for development as well as marketing costs
- General Secretariat for Research and Technology (GSRT) |
3. Private funding |
- Joint venture with potential investor
- Personal capital |
SECTION 3: FINAL EVALUATION
|
Decision of evaluation (Please keep only the appropriate)
- The R&D has a high potential of exploitation v